Abstract
Chronic dust bronchitis (CDB) is one of the most common occupational diseases among employees of coal-cycle enterprises. Until recently, the lungs were considered to be sterile, but, in recent years, studies have shown that this is not the case. However, the contribution of microbiota and individual bacterial taxa to the etiology and pathogenesis of many respiratory-tract diseases remains unclear. The aim of the study to determine the taxonomic composition of the bacterial microbiota of the upper respiratory tract of patients with CDB. Sputum samples were obtained from patients with CDB (n = 22, men) and healthy auditorial donors (n = 22, men). Sequencing of variable regions V3–V4 of the 16S pRNA gene was used to study the complete taxonomic composition of the respiratory microbiome. The study revealed a significant decrease in the α diversity of bacterial microbiota in the sputum of patients with CDB compared to the Shannon index control (H = 9.795; p = 0.0017). The PERMANOVA test using a matrix of differences constructed by the Bray–Curtis method showed a significant difference in β diversity between the compared samples (pseudo-F = 2.11; p = 0.002). In the sputum microbiome of patients with CDB, compared with the control, an increase in the relative abundance of bacteria of the genus Streptococcus was found (29.97 ± 14.21 vs. 18.78 ± 11.56; p = 0.006). The taxonomic profile of the respiratory microbiome in the study group of patients with CDB differs from that of healthy people. An increase in the relative abundance of bacteria of the genus Streptococcus in the sputum microbiome of patients with CDB suggests a general dysbiotic process with the accentuation of one dominant genus of microorganisms in this pulmonary pathology.
REFERENCES
Bakirov, A.B., Mingazova, S.R., Karimova, L.K., Serebryakov, P.V., and Mukhammadieva, G.F., Risk of dust bronchopulmonary pathology development in workers employed in various economic brunches under impacts exerted by occupational risk factors: clinical and hygienic aspects, Health Risk Anal., 2017, no. 3, pp. 83–91. https://doi.org/10.21668/health.risk/2017.3.10
Dickson, R.P., Erb-Downward, J.R., and Huffnagle, G.B., The role of the bacterial microbiome in lung disease, Expert Rev. Respir. Med., 2013, vol. 7, no. 3, pp. 245–257. https://doi.org/10.1586/ers.13.24
Qi, Y.J., Sun, X.J., Wang, Z., Bin, Y.F., Li, Y.H., Zhong, X.N., et al., Richness of sputum microbiome in acute exacerbations of eosinophilic chronic obstructive pulmonary disease, Chin. Med. J., 2020, vol. 133, no. 5, pp. 542–551. https://doi.org/10.1097/CM9.0000000000000677
Kozik, A.J. and Huang, Y.J., The microbiome in asthma: Role in pathogenesis, phenotype, and response to treatment, Ann. Allergy, Asthma, Immunol., 2019, vol. 122, no. 3, pp. 270–275. https://doi.org/10.1016/j.anai.2018.12.005
Wootton, D.G., Cox, M.J., Gloor, G.B., Litt, D., Hoschler, K., German, E., et al., A Haemophilus sp. dominates the microbiota of sputum from UK adults with non-severe community acquired pneumonia and chronic lung disease, Sci. Rep., 2019, vol. 9, no. 1, p. 2388. https://doi.org/10.1038/s41598-018-38090-5
Acosta, N., Heirali, A., Somayaji, R., Surette, M.G., Workentine, M.L., Sibley, C.D., et al., Sputum microbiota is predictive of long-term clinical outcomes in young adults with cystic fibrosis, Thorax, 2018, vol. 73, no. 11, pp. 1016–1025. https://doi.org/10.1136/thoraxjnl-2018-211510
Maddi, A., Sabharwal, A., Violante, T., Manuballa, S., Genco, R., Patnaik, S., et al., The microbiome and lung cancer, J. Thorac. Dis., 2019, vol. 11, no. 1, pp. 280–291. https://doi.org/10.21037/jtd.2018.12.88
Hewitt, R.J. and Molyneaux, P.L., The respiratory microbiome in idiopathic pulmonary fibrosis, Ann. Transl. Med., 2017, vol. 5, no. 12, p. 250. https://doi.org/10.21037/atm.2017.01.56
Goleva, E., Jackson, L.P., Harris, J.K., Robertson, C.E., Sutherland, E.R., Hall, C.F., et al., The effects of airway microbiome on corticosteroid responsiveness in asthma, Am. J. Respir. Crit. Care Med., 2013, vol. 188, no. 10, pp. 1193–1201. https://doi.org/10.1164/rccm.201304-0775OC
Huffnagle, G., Dickson, R., and Lukacs, N., The respiratory tract microbiome and lung inflammation: A two-way street, Mucosal Immunol., 2017, vol. 10, no. 2, pp. 299–306. https://doi.org/10.1038/mi.2016.108
Dickson, R.P., Erb-Downward, J.R., Martinez, F.J., and Huffnagle, G.B., The microbiome and the respiratory tract, Annu. Rev. Physiol., 2016, vol. 78, pp. 481–504. https://doi.org/10.1146/annurev-physiol-021115-105238
Dickson, R.P., Erb-Downward, J.R., Freeman, C.M., McCloskey, L., Beck, J.M., Huffnagle, G.B., et al., Spatial variation in the healthy human lung microbiome and the adapted island model of lung biogeography, Ann. Am. Thorac. Soc., 2015, vol. 12, no. 6, pp. 821–830. https://doi.org/10.1513/AnnalsATS.201501-029OC
Sperandio, V., Torres, A.G., Jarvis, B., Nataro, J.P., and Kaper, J.B., Bacteria–host communication: The language of hormones, Proc. Natl. Acad. Sci. U. S. A., 2003, vol. 100, no. 15, pp. 8951–8956. https://doi.org/10.1073/pnas.1537100100
Manning, S.D., Molecular epidemiology of Streptococcus agalactiae (group B Streptococcus), Front. Biosci., 2003, vol. 8, pp. 1–18. https://doi.org/10.2741/985
Sharma, P., Lata, H., Arya, D.K., Kashyap, A.K., Kumar, H., et al., Role of pilus proteins in adherence and invasion of Streptococcus agalactiae to the lung and cervical epithelial cells, J. Biol. Chem., 2012, vol. 288, no. 6, pp. 4023–4034. https://doi.org/10.1074/jbc.m112.425728
Wu, X., Deng, G., Li, M., Li, Y., Ma, C., Wang, Y., et al., Wnt/β-catenin signaling reduces Bacillus Calmette–Guerin-induced macrophage necrosis through a ROS-mediated PARP/AIF-dependent pathway, BMC Immunol., 2015, vol. 16, p. 16. https://doi.org/10.1186/s12865-015-0080-5
Han, M.K., Zhou, Y., Murray, S., Tayob, N., Noth, I., Lama, V.N., et al., Lung microbiome and disease progression in idiopathic pulmonary fibrosis: An analysis of the COMET study, Lancet Respir. Med., 2014, vol. 2, no. 7, pp. 548–556. https://doi.org/10.1016/S2213-2600(14)70069-4
Cameron, S.J.S., Lewis, K.E., Huws, S.A., Hegarty, M.J., Lewis, P.D., Pachebat, J.A., et al., A pilot study using metagenomic sequencing of the sputum microbiome suggests potential bacterial biomarkers for lung cancer, PLoS One, 2017, vol. 12, no. 5, p. e0177062. https://doi.org/10.1371/journal.pone.0177062
Einarsson, G.G., Comer, D.M., McIlreavey, L., Parkhill, J., Ennis, M., Tunney, M.M., et al., Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers, Thorax, 2016, vol. 71, no. 9, pp. 795–803. https://doi.org/10.1136/thoraxjnl-2015-207235
Wang, Z., Liu, H., Wang, F., Yang, Y., Wang, X., Chen, B., et al., A refined view of airway microbiome in chronic obstructive pulmonary disease at species and strain-levels, Front. Microbiol., 2020, vol. 30, no. 11, p. 1758. https://doi.org/10.3389/fmicb.2020.01758
Funding
This work was supported by the Russian Science Foundation, grant no. 18-14-00022p.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Statement of Compliance with Standards of Research Involving Humans as Subjects
All procedures performed in studies involving human participants were following the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All participants were informed about the purpose, methodology, and possible risks of the study; informed consent was signed by each donor. The study was carried out following the requirements of the Ethical Committee of Kemerovo State University. The study was approved by the Biomedical Ethics Commission of Kemerovo State University, protocol no. 17/2021 dated April 5, 2021.
Conflict of Interest
The authors declare that they have no conflicts of interest.
Additional information
Tranlated by V. Mittova
About this article
Cite this article
Paradnikova, S.A., Druzhinin, V.G., Baranova, E.D. et al. Specifics of the Taxonomic Composition of Bacterial Microflora in the Respiratory Microbiome of Patients with Chronic Dust Bronchitis. Mol. Genet. Microbiol. Virol. 38, 70–78 (2023). https://doi.org/10.3103/S0891416823020076
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.3103/S0891416823020076